India’s External Affairs Minister S Jaishankar met with US Secretary of State Antony Blinken on May 04, 2021, during his visit to London, UK.
EAM Jaishankar is visiting London from May 03 – May 06, 2021, to participate in the G7 Foreign Ministers Meeting, to which India has been invited as a guest country.
Jaishankar and Blinken deliberated on how to tackle the COVID-19 pandemic, focusing on expanding vaccine production and reliable supply chains during the G7 Foreign and Development Minister’s Meeting.
Jaishankar also thanked his US counterpart for the support extended by the United States, especially the supply of Remdesivir and oxygen, during India’s battle against COVID-19.
Jaishankar and Blinken also touched upon the issues related to the India-Pacific region, Myanmar, UN Security Council, and climate change.
India’s External Affairs Minister Jaishankar posted on Twitter about his meeting with Blinken.
Good to meet in person my old friend @SecBlinken. Detailed discussion on the global Covid challenge, focussing on expanded vaccine production capacity and reliable supply chains. pic.twitter.com/iQZmGjuPi5
— Dr. S. Jaishankar (@DrSJaishankar) May 3, 2021
US Secretary of State Antony Blinken also took it to Twitter to share glimpses of the discussion among the leaders at the G7 Foreign and Development Minister’s Meeting.
Met today with @DrSJaishankar to discuss our joint efforts to combat COVID-19 and to advance our broader comprehensive global strategic partnership. India is a close friend and partner, and I look forward to further deepening the unique partnership between our two nations. pic.twitter.com/flYtYWeQ8p
— Secretary Antony Blinken (@SecBlinken) May 3, 2021
About the G7
The G7, or the Group of 7, is a forum that brings together leaders from seven countries across the world. The seven-member countries are the United Kingdom, the United States, Japan, Italy, Germany, France, Canada, and the European Union (EU). Founded in 1975, the group meets to discuss gripping world issues.
Comments
All Comments (0)
Join the conversation